These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 32716575)

  • 1. Significance of cytosolic cathepsin D in Alzheimer's disease pathology: Protective cellular effects of PLGA nanoparticles against β-amyloid-toxicity.
    Wang Y; Wu Q; Anand BG; Karthivashan G; Phukan G; Yang J; Thinakaran G; Westaway D; Kar S
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):686-706. PubMed ID: 32716575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis.
    Terron HM; Parikh SJ; Abdul-Hay SO; Sahara T; Kang D; Dickson DW; Saftig P; LaFerla FM; Lane S; Leissring MA
    Alzheimers Res Ther; 2024 Apr; 16(1):70. PubMed ID: 38575959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration.
    Chai YL; Chong JR; Weng J; Howlett D; Halsey A; Lee JH; Attems J; Aarsland D; Francis PT; Chen CP; Lai MKP
    Brain Pathol; 2019 Jan; 29(1):63-74. PubMed ID: 30051532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of alzheimer's disease.
    Govindarajan K; Kar S
    J Nanobiotechnology; 2023 Jul; 21(1):216. PubMed ID: 37424018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native PLGA nanoparticles regulate APP metabolism and protect neurons against β-amyloid toxicity: Potential significance in Alzheimer's disease pathology.
    Wu Q; Karthivashan G; Nakhaei-Nejad M; Anand BG; Giuliani F; Kar S
    Int J Biol Macromol; 2022 Oct; 219():1180-1196. PubMed ID: 36030976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unconjugated PLGA nanoparticles attenuate temperature-dependent β-amyloid aggregation and protect neurons against toxicity: implications for Alzheimer's disease pathology.
    Paul PS; Cho JY; Wu Q; Karthivashan G; Grabovac E; Wille H; Kulka M; Kar S
    J Nanobiotechnology; 2022 Feb; 20(1):67. PubMed ID: 35120558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of positive lysosomal modulation in Alzheimer's disease transgenic mouse models.
    Butler D; Hwang J; Estick C; Nishiyama A; Kumar SS; Baveghems C; Young-Oxendine HB; Wisniewski ML; Charalambides A; Bahr BA
    PLoS One; 2011; 6(6):e20501. PubMed ID: 21695208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of β-amyloid1-42 internalization attenuates neuronal death by stabilizing the endosomal-lysosomal system in rat cortical cultured neurons.
    Song MS; Baker GB; Todd KG; Kar S
    Neuroscience; 2011 Mar; 178():181-8. PubMed ID: 21262324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Native PLGA nanoparticles attenuate Aβ-seed induced tau aggregation under in vitro conditions: potential implication in Alzheimer's disease pathology.
    Paul PS; Patel T; Cho JY; Yarahmady A; Khalili A; Semenchenko V; Wille H; Kulka M; Mok SA; Kar S
    Sci Rep; 2024 Jan; 14(1):144. PubMed ID: 38167993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of exosomes derived from cholesterol-accumulated astrocytes in Alzheimer's disease pathology.
    Wu Q; Cortez L; Kamali-Jamil R; Sim V; Wille H; Kar S
    Dis Model Mech; 2021 Oct; 14(10):. PubMed ID: 34524402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endolysosome involvement in LDL cholesterol-induced Alzheimer's disease-like pathology in primary cultured neurons.
    Hui L; Chen X; Geiger JD
    Life Sci; 2012 Dec; 91(23-24):1159-68. PubMed ID: 22580286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged In Vivo Retention of a Cathepsin D Targeted Optical Contrast Agent in a Mouse Model of Alzheimer's Disease.
    Snir JA; Suchy M; Lawrence KS; Hudson RH; Pasternak SH; Bartha R
    J Alzheimers Dis; 2015; 48(1):73-87. PubMed ID: 26401930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: Implications for Alzheimer disease pathogenesis.
    Terron HM; Parikh SJ; Abdul-Hay SO; Sahara T; Kang D; Dickson DW; Saftig P; LaFerla FM; Lane S; Leissring MA
    Res Sq; 2023 Oct; ():. PubMed ID: 37961253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological expression of mutated TAU impaired astrocyte activity and exacerbates β-amyloid pathology in 5xFAD mice.
    Farfara D; Sooliman M; Avrahami L; Royal TG; Amram S; Rozenstein-Tsalkovich L; Trudler D; Blanga-Kanfi S; Eldar-Finkelman H; Pahnke J; Rosenmann H; Frenkel D
    J Neuroinflammation; 2023 Jul; 20(1):174. PubMed ID: 37496076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of cathepsin D in monocytes is related to the defective degradation of amyloid-β in Alzheimer's disease.
    Tian L; Zhang K; Tian ZY; Wang T; Shang DS; Li B; Liu DX; Fang WG; Wang ZY; Chen YH
    J Alzheimers Dis; 2014; 42(2):511-20. PubMed ID: 24898658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of native PLGA nanoparticles in the treatment of Alzheimer's disease pathology.
    Anand B; Wu Q; Nakhaei-Nejad M; Karthivashan G; Dorosh L; Amidian S; Dahal A; Li X; Stepanova M; Wille H; Giuliani F; Kar S
    Bioact Mater; 2022 Nov; 17():506-525. PubMed ID: 36330076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Death-associated protein kinase 1 mediates Aβ42 aggregation-induced neuronal apoptosis and tau dysregulation in Alzheimer's disease.
    Zhang T; Xia Y; Hu L; Chen D; Gan CL; Wang L; Mei Y; Lan G; Shui X; Tian Y; Li R; Zhang M; Lee TH
    Int J Biol Sci; 2022; 18(2):693-706. PubMed ID: 35002518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 14,15-Epoxyeicosatrienoic Acid Alleviates Pathology in a Mouse Model of Alzheimer's Disease.
    Chen W; Wang M; Zhu M; Xiong W; Qin X; Zhu X
    J Neurosci; 2020 Oct; 40(42):8188-8203. PubMed ID: 32973044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.
    Guzmán EA; Bouter Y; Richard BC; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Wirths O; Bayer TA
    Mol Neurodegener; 2014 Apr; 9():13. PubMed ID: 24694184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.